SCHEMBL22152251

SCHEMBL22152251

CS(=O)(=O)OC1CN(c2ccc(Cl)cn2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 1/20 0.49
▸ CNR2 P34972 1/20 0.42
▸ SMO Q99835 1/20 0.39
▸ KMT2A Q03164 1/20 0.38
▸ GRM4 Q14833 1/20 0.38
▸ HTR1A P08908 2/20 0.38
▸ DRD4 P21917 2/20 0.38
▸ HTR2A P28223 2/20 0.38
▸ SLC6A4 P31645 2/20 0.38
▸ HTR7 P34969 2/20 0.38
▸ DRD3 P35462 2/20 0.38
▸ PDE10A Q9Y233 1/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ DPP4 P27487 1/20 0.37
▸ PREP P48147 1/20 0.37
▸ DPP8 Q6V1X1 1/20 0.37
▸ DPP7 Q9UHL4 1/20 0.37
▸ PANK3 Q9H999 1/20 0.37
▸ TRPA1 O75762 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17559324 0.84 GPR119 (0.48) GPR119SMOKMT2ADRD3PDE10A
SCHEMBL22153203 0.80 PDE10A (0.46) GPR119CNR2KMT2AGRM4HTR1A
SCHEMBL23057532 0.80 ACACB (0.49) GPR119
SCHEMBL28939074 0.80 GPR119 (0.52) GPR119GRM4DPP4PREPDPP8
SCHEMBL22129420 0.78 SMO (0.39) SMO
SCHEMBL22129422 0.75 PDE10A (0.50) GPR119CNR2KMT2AGRM4HTR1A
SCHEMBL12683431 0.75 CNR2 (0.46) GPR119CNR2KMT2AGRM4HTR1A
SCHEMBL389971 0.73 ACACB (0.43) GPR119PDE10A
SCHEMBL389972 0.73 ACACB (0.43) GPR119PDE10A
SCHEMBL390047 0.73 ACACB (0.43) GPR119PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111333626-B Phenyl pyrrolidine compounds and uses thereof 武汉人福创新药物研发中心有限公司 2022-10-18 — — CN disclosed
US-20220056014-A1 PHENYLPYRROLIDINE COMPOUND AND USE THEREOF Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2022-02-24 — — US disclosed
EP-3901146-A1 PHENYLPYRROLIDINE COMPOUND AND USE THEREOF Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2021-10-27 — — EP disclosed
WO-2020125627-A1 PHENYLPYRROLIDINE COMPOUND AND USE THEREOF 湖北生物医药产业技术研究院有限公司 2020-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220056014-A1 PHENYLPYRROLIDINE COMPOUND AND USE THEREOF PAH, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AVPR2 GPR119 1424/4885CNR2 41/4885SMO 4546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback